Product
TIVY-IB
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
Double-blind, Randomized Clinical Trial With Active Controls to Assess Safety, Immunogenicity and Lot-to-lot Consistency of Inactivated Split-virion Quadrivalent Influenza Vaccine of Butantan InstituteStatus: Active (not recruiting), Estimated PCD: 2023-07-08